Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Global Burden of Disease 2021: Findings from the GBD 2021 Study.Seattle, WA: IHME
they are rebuilding them from scratch to match the cultural, linguistic and regulatory context of each country
A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease
Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study
US$ 29.75
US$ 20.58
US$ 29.90
US$ 22.25
US$ 28.22
US$ 23.58
US$ 22.46
